Affiliation:
1. Department of Epidemiology University of Michigan Ann Arbor MI
2. University of Michigan Medical School Ann Arbor MI
3. School of Public Health, University of Washington Seattle WA
4. Department of Epidemiology, Harvard T.H. Chan School of Public Health Boston MA
5. VA Normative Aging Study Veterans Affairs Boston Health Care System Boston MA
6. Department of Medicine Boston University School of Medicine Boston MA
Abstract
Background
Bone lead offers a better method over blood lead measurement to discern long‐term lead exposure and accumulation. We examined the risk of resistant hypertension based on bone lead levels in a prospective cohort study of NAS (Normative Aging Study).
Methods and Results
Participants had clinic data on hypertension (systolic blood pressure, diastolic blood pressure, and antihypertension medication), lead (blood, bone‐patella, bone‐tibia), and demographic and confounding variables. Cases of resistant hypertension were identified by meeting criteria for: (1) inadequate systolic blood pressure (>140 mm Hg) or diastolic blood pressure (>90 mm Hg) while taking 3 medications or (2) requiring >4 medications for blood pressure control. A modified Poisson regression was used for model analysis. Of the 475 participants, 97 cases of resistant hypertension (20.4%) were identified. Among the cases of resistant hypertension, the median tibia and patella lead levels were 20 μg/g and 25 μg/g, respectively, while median tibia and patella lead levels were 20 μg/g and 27.5 μg/g, respectively, in participants without resistant hypertension. Tibia lead demonstrated a significant association with resistant hypertension (relative risk, 1.19; 95% confidence interval, 1.01–1.41 [
P
=0.04]) per interquartile range increase in tibia lead (13–28.5 μg/g). Patella lead was not associated with resistant hypertension (relative risk, 1.10; 95% confidence interval, 0.92–1.31 [
P
=0.31]) per interquartile range increase in patella lead (18–40 μg/g). Blood lead levels were not significantly associated with resistant hypertension (relative risk, 1.11; 95% confidence interval, 0.88–1.40 [
P
=0.38]).
Conclusions
Tibia lead represents a novel risk factor for resistant hypertension. Our study demonstrates an increased association between tibia lead and resistant hypertension status, with an increased risk of 19% per 1 interquartile range increase in tibia lead.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Reference39 articles.
1. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011–2012;Nwankwo T;NCHS Data Brief,2013
2. Centers for Disease Control and Prevention
. High Blood Pressure Fact Sheet. 2016. Available at: https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_bloodpressure.htm. Accessed October 2 2018.
3. Heart disease and stroke Statistics—2018 update: a report from the American Heart Association;American Heart Association;Circulation,2018
4. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults;American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Hypertension,2018
5. Deaths Preventable in the U.S. by Improvements in Use of Clinical Preventive Services
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献